BAGGER RICHARD H 4

What Happened Richard H. Bagger, a director of Tonix Pharmaceuticals Holding Corp. (TNXP), was granted an award covering 22,700 shares on May 12, 2026. The award is reported as a derivative acquisition at $0.00 per share (no cash paid) and was granted under the Issuer's 2026 Stock Incentive Plan. This is a compensatory grant rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-05-12; Form 4 filed 2026-05-14 (filed within the typical two-business-day window).
• Transaction type/code: Award/Grant (derivative) — reported as A; price reported $0.00.
• Shares involved: 22,700 option/award shares granted.
• Vesting: Per footnote, vests on the earlier of the one-year anniversary of the grant date and the Issuer's 2027 Annual Meeting of Stockholders.
• Shares owned after transaction: not specified in the provided filing excerpt.

Context This was a standard equity compensation grant to a director. Such grants do not require an immediate cash outlay and may dilute existing shareholders if and when options are exercised or awards settle into shares. Because this filing reports a grant (not a sale), it does not by itself indicate buying or selling sentiment by the insider.